| Systemic Sclerosis and Related Diseases | Lifetime | 9 | IT 2 | 99.78 |
| Dermatologic Treatments and Research | Lifetime | 10 | IT 2 | 99.73 |
| Mast cells and histamine | Lifetime | 23 | IT 2 | 99.43 |
| Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis | Lifetime | 56 | IT 2 | 99.52 |
| Inflammatory Myopathies and Dermatomyositis | Lifetime | 27 | IT 1 | 99.41 |
| Connective Tissue Growth Factor Research | Lifetime | 9 | IT 1 | 99.13 |
| Hypertrophic osteoarthropathy and related conditions | Lifetime | 2 | IT 1 | 97.78 |
| Pulmonary Hypertension Research and Treatments | Lifetime | 363 | IT 9 | 98.14 |
| Dermatological and Skeletal Disorders | Lifetime | 97 | IT 8 | 97.78 |
| Rheumatoid Arthritis Research and Therapies | Lifetime | 416 | IT 20 | 98.26 |
| Urticaria and Related Conditions | Lifetime | 251 | IT 14 | 97.64 |
| Eosinophilic Disorders and Syndromes | Lifetime | 368 | IT 33 | 97.29 |
| Skin Diseases and Diabetes | Lifetime | 85 | IT 6 | 97.51 |
| Systemic Lupus Erythematosus Research | Lifetime | 920 | IT 74 | 97.45 |
| Diagnosis and Treatment of Venous Diseases | Lifetime | 270 | IT 16 | 96.47 |
| Spondyloarthritis Studies and Treatments | Lifetime | 293 | IT 26 | 97.03 |
| Autoimmune Bullous Skin Diseases | Lifetime | 516 | IT 41 | 96.59 |
| Autoimmune and Inflammatory Disorders Research | Lifetime | 599 | IT 54 | 96.45 |
| Biosimilars and Bioanalytical Methods | Lifetime | 333 | IT 16 | 94.78 |
| Coagulation, Bradykinin, Polyphosphates, and Angioedema | Lifetime | 917 | IT 59 | 94.28 |
| Lymphatic System and Diseases | Lifetime | 501 | IT 21 | 91.22 |
| Dupuytren's Contracture and Treatments | Lifetime | 259 | IT 6 | 86.59 |
| Sympathectomy and Hyperhidrosis Treatments | Lifetime | 760 | IT 77 | 83.09 |
| Medicine and Dermatology Studies History | Lifetime | 820 | IT 17 | 81.28 |
| Systemic Sclerosis and Related Diseases | 2021-2025 | 6 | IT 1 | 99.60 |
| Dermatologic Treatments and Research | 2021-2025 | 14 | IT 2 | 98.65 |
| Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis | 2021-2025 | 60 | IT 8 | 98.73 |
| Inflammatory Myopathies and Dermatomyositis | 2021-2025 | 22 | IT 2 | 98.53 |
| Connective Tissue Growth Factor Research | 2021-2025 | 2 | IT 1 | 96.80 |
| Mast cells and histamine | 2021-2025 | 32 | IT 3 | 96.41 |
| Eosinophilic Disorders and Syndromes | 2021-2025 | 95 | IT 16 | 95.80 |
| Rheumatoid Arthritis Research and Therapies | 2021-2025 | 446 | IT 51 | 93.68 |
| Diagnosis and Treatment of Venous Diseases | 2021-2025 | 166 | IT 11 | 89.39 |
| Skin Diseases and Diabetes | 2021-2025 | 69 | IT 7 | 81.78 |
| Autoimmune and Inflammatory Disorders Research | 2021-2025 | 644 | IT 79 | 87.49 |
| Autoimmune Bullous Skin Diseases | 2021-2025 | 542 | IT 80 | 84.80 |
| Sarcoidosis and Beryllium Toxicity Research | 2021-2025 | 714 | IT 54 | 75.17 |
| Biosimilars and Bioanalytical Methods | 2021-2025 | 927 | IT 49 | 73.20 |
| Salivary Gland Disorders and Functions | 2021-2025 | 969 | IT 84 | 67.58 |
| Otitis Media and Relapsing Polychondritis | 2021-2025 | 511 | IT 64 | 64.39 |
| Lymphatic System and Diseases | 2021-2025 | 890 | IT 61 | 60.57 |
| Dermatological and Skeletal Disorders | 2021-2025 | 677 | IT 101 | 47.44 |
| Dermatological and COVID-19 studies | 2021-2025 | 887 | IT 164 | 46.41 |
